Navigation Links
Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
Date:10/2/2007

BERKELEY, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (OTC Bulletin Board: SPDU.OB), announced today that Peter M. Strumph, Chief Executive Officer, will present at the Biotechnology Industry Organization (BIO) Investor Forum on Thursday, October 11, 2007 at 12:30 p.m. Pacific Time at The Palace Hotel in San Francisco, California. Mr. Strumph will provide an overview of Nile and an update on its clinical development programs, including data from Nile's recently completed Phase Ia study for its lead compound, CD-NP.

The presentation will be webcast live and can be accessed by visiting the Investor Relations section at http://www.nilethera.com. The webcast will be archived for ninety days. Additional information regarding the BIO Investor Forum can be accessed at http://investorforum.bio.org.

About Nile Therapeutics, Inc.

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is developing innovative products for the treatment of cardiovascular disease. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel chimeric peptide in Phase I studies for the treatment of heart failure and 2NTX-99, a small molecule, pre-clinical, anti-atherothrombotic agent with nitric oxide (NO) donating properties.

CD-NP, a novel chimeric natriuretic peptide currently in Phase I clinical studies for the treatment of heart failure, is a selective NPRB agonist which, in vivo, has been shown to have potent renal enhancement and cardiac unloading properties but with minimal hypotensive effects compared with competitive products. CD-NP is a rationally-designed synthetic peptide designed to incorporate favorable properties of naturally occurring natriuretic peptides. Data from Nile's recently completed Phase Ia study in healthy volunteers confirmed several pre-clinical findings, includin
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  United Therapeutics ... that it will release its second quarter 2014 ... 29, 2014. United Therapeutics will host ... at 9:00 a.m. Eastern Time.  The teleconference is ... 1-970-315-0533.  A rebroadcast of the teleconference will be ...
(Date:7/22/2014)... July 22, 2014 Dr. Williams says, ... who have recognized that the greatest health care system ... too often needlessly deadly while trying to serve the ... quasi-experts seeking to transform an enormous system that none ... Williams, in his continuing series of Open Letters ( ...
(Date:7/21/2014)... yield so far is small, but chemists at the ... substitution process to make a precursor to transparent thin ... energy devices. , A paper describing the approach is ... of the journal Inorganic Chemistry , which draws ... nuclear chemistry fields. The paper was chosen by the ...
(Date:7/20/2014)... NY (PRWEB) July 20, 2014 ... custom quartz glass optics, and spectrophotometer calibration ... these years, NSG has released many products that ... successful product has been their solid-state calibration standards. ... liquid standards since their release in 2008. ...
Breaking Biology Technology:Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2Oregon chemists eye improved thin films with metal substitution 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3
... AVIV, Israel, October 15 ,Simbionix USA Corporation is ... round of growth capital financing led by River ... Partners and other existing,shareholders, as well as Western ... The investment will enable Simbionix to,accelerate the already ...
... PURE Bioscience (Nasdaq:,PURE), creators of the patented ... the fiscal year ended July 31, 2008 of,$1,487,500, ... in the,prior fiscal year. The Company reported a ... per share, compared with a loss of,$(4,654,900), or ...
... Calif., Oct. 15 SuperGen, Inc.,(Nasdaq: SUPG ... and,development of novel cancer therapies, today announced the ... EORTC-NCI-AACR Symposium on "Molecular,Targets and Cancer Therapeutics" on ... will review clinical and non-clinical advances,in the following ...
Cached Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3PURE Bioscience Reports Fourth Quarter and Year End Results 2PURE Bioscience Reports Fourth Quarter and Year End Results 3PURE Bioscience Reports Fourth Quarter and Year End Results 4PURE Bioscience Reports Fourth Quarter and Year End Results 5PURE Bioscience Reports Fourth Quarter and Year End Results 6PURE Bioscience Reports Fourth Quarter and Year End Results 7SuperGen to Present Data at EORTC-NCI-AACR 2
(Date:7/21/2014)... areas across Riau province on Sunday, July 20, indicating ... decline in rainfall. The number of detected hotspots ... been reported one day prior, which had reached only ... regencies and municipalities, most of which were in northern ... creates could potentially spread via winds to Malaysia and ...
(Date:7/21/2014)... CHAMPAIGN, Ill. A new study in mice reveals ... muscle after resistance exercise. , By injecting MSCs ... eccentric exercise (similar to the lengthening contractions performed during ... damage), researchers were able to increase the rate of ... muscles in the exercising mice. , The findings, ...
(Date:7/21/2014)... yourself full of high-fat foods cause you to lose ... Florida State University neuroscientists says so, and it has ... could impact a whole range of human functions that ... obesity. , "This opens up a lot of possibilities ... Nicolas Thiebaud, who led the study examining how high-fat ...
Breaking Biology News(10 mins):Stem cells aid muscle repair and strengthening after resistance exercise 2New research links bad diet to loss of smell 2
... trillions of cells, all derived from a single cell, or zygote, ... single cell contains all the genetic information needed to develop into ... new cell as it divides into the many diverse types of ... If each cell is genetically identical, however, how does ...
... make sure their children drink milk and eat other calcium-rich foods ... make sure their kids eat salmon, almonds and other foods high ... in bone health, according to a study to be presented Sunday, ... Washington, DC. "Lots of nutrients are key for children ...
... and/or improve the quality of life for many cancer patients. ... inducing damage to DNA. The public has an opportunity ... used anticancer drugs and how laboratory research may lead to ... Yinsheng Wang , a professor of chemistry at ...
Cached Biology News:Divide and define: Clues to understanding how stem cells produce different kinds of cells 2Divide and define: Clues to understanding how stem cells produce different kinds of cells 3Magnesium may be as important to kids' bone health as calcium 2How do anticancer drugs work? 2How do anticancer drugs work? 3
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Immunogen: Recombinant human IDO (Indoleamine-pyrrol ... the ~44 kDa human IDO ... control: IFN-Gamma-stimmulated Human peripheral blood ... reactivity with mouse and rat ...
...
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
Biology Products: